What's Next For BMY Stock After An Upbeat Q3?
Bristol Myers Squibb exceeded Q3 revenue and earnings estimates, raising its full-year outlook. The stock gained 6% in a week. Revenue grew 8% y-o-y, with strong performance in growth portfolio. Adjusted earnings were $1.80 per share.